This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 203395-81-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shanghai
Inquiry
203395-81-7 / 7-[4-[4-(2-chlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
Standard CAS: 203395-81-7
Multi CAS: No
Basic Information
copy
CAS
203395-81-7 copy
Multi CAS
No copy
Molecular Formula
C23H28ClN3O2 copy
Molecular Weight
413.900000 copy
Exact Mass
413.187005 copy
SMILES
C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=CC=CC=C4Cl copy
InChI
InChI=1S/C23H28ClN3O2/c24-20-5-1-2-6-22(20)27-14-12-26(13-15-27)11-3-4-16-29-19-9-7-18-8-10-23(28)25-21(18)17-19/h1-2,5-7,9,17H,3-4,8,10-16H2,(H,25,28) copy
InChIKey
YZWZYPOWFMWSAH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
29 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.43 copy
Rotatable bonds
7 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
118.23 copy
TPSA
44.81 copy
LogP / Solubility
WLOGP
4.21 copy
MLOGP
3.73 copy
XLogP3
4 copy
Consensus LogP
3.98 copy
Log S (ESOL)
-4.9 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.99 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-6.68 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.26 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy